Novartis' Jakavi turns out positive PhIII results in PV; 'Are you prepared for anaphylaxis?' Adrian Peterson asks;

> Phase III data show polycythemia vera patients on Novartis' ($NVS) Jakavi achieved significant improvement in disease control. Release

> Johnson & Johnson ($JNJ) has shifted its U.S. media buying account to OMD, part of the Omnicom Media Group division of the Omnicom Group. More (sub. req.)

> AbbVie ($ABBV), Astellas and Roche ($RHHBY) have been nominated for the Pegasus Award for In-House Team of the Year at Communiqué. More

> Brand experience agency SSG Create has secured Botox-maker Allergan ($AGN) as a client. Report

> IDEA Pharma has appointed UPenn research specialist Rick Ritacco to its New York practice. Release

> Jack Morton Worldwide has opened an office in Düsseldorf, Germany, following client wins with Novartis ($NVS) and Merck Serono. More

> Johnson & Johnson ($JNJ), a World Cup sponsor through its Listerine and Regaine brands, has helped fuel growth at sponsorship agency Prism. More

And Finally... EpiPen maker Mylan ($MYL) and NFL star Adrian Peterson are calling on Americans to learn to be aware and prepared for anaphylaxis. Release

Suggested Articles

Cardiac risks associated with roxadustat are comparable to placebo in nondialysis patients and to Amgen's standard, Epogen, in those on dialysis.

Pfizer and Merck KGaA's immuno-oncology agent Bavencio failed another gastric cancer study, this time as a maintenance treatment after chemotherapy.

A jury ordered Biogen to pay nearly $6 million to a former sales manager who reported a colleague's misconduct and got fired a few months later.